Ticker Scorecard - BIIB Basics Company: Biogen Inc. IPO Date: January 3, 1994 Sector: Healthcare Industry: Biotech Market Cap: $20.76B Activated in VL: True Average Daily Range Avg Daily Range: $2.48 | 1.32% Avg Daily Range (30 D): $1.86 | 1.26% Avg Daily Range (90 D): $1.91 | 1.15% Institutional Daily Volume Avg Daily Volume: 2.1M Avg Daily Volume (30 D): 1.01M Avg Daily Volume (90 D): 1.09M Trade Size Avg Trade Size (Sh.): 110 Avg Trade Size (Sh.) (30 D): 39 Avg Trade Size (Sh.) (90 D): 40 Institutional Trades Total Inst.Trades: 43,713 Avg Inst. Trade: $5.92M Avg Inst. Trade (30 D): $14.1M Avg Inst. Trade (90 D): $14.96M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 8 Market Closing Trades Avg Closing Trade: $27.54M Avg Closing Trade (30 D): $45.68M Avg Closing Trade (90 D): $38.07M Avg Closing Volume: 129.86K     News Feb 5, 2025 @ 12:30 AM Global Water Flavouring Drops Market Poised for Su... Source: Future Market Insights, Inc. Feb 3, 2025 @ 9:52 AM Orphan Designated Drugs Market Analysis: Key Trend... Source: Na Jan 31, 2025 @ 7:20 PM Deal Dispatch: Sage And Silvus Are Up For Sale, Mr... Source: Anthony Noto Jan 31, 2025 @ 2:00 PM Recombinant Chemicals Market to Reach US$ 6.7 Bn b... Source: Transparency Market Research Inc. Jan 27, 2025 @ 3:49 PM Biological Drugs Strategic Research Report 2024-20... Source: Na Financials   TTM Q3 2024 Q2 2024 Basic EPS $11.1 $2.67 $4.01 Diluted EPS $11.06 $2.66 $4 Revenue $ 9.61B $ 2.47B $ 2.46B Gross Profit $ 7.26B $ 1.83B $ 1.92B Net Income / Loss $ 1.61B $ 388.5M $ 583.6M Operating Income / Loss $ 1.91B $ 451M $ 698.7M Cost of Revenue $ 2.35B $ 638.7M $ 546M Net Cash Flow $ -588.7M $ -209.7M $ 834.5M PE Ratio 0.00     Splits Jan 18, 2001:   1:3